Low-Dose Edoxaban Effective in Elderly Patients with Atrial Fibrillation

פוסט זה זמין גם ב: עברית

A 15-mg daily dose was sufficient to significantly reduce the annualized rate of stroke or systemic embolism, compared with placebo.